An anti-cancer pill from Merck & Co can fight tumors and is safe in combination with palliative radiotherapy for patients with advanced pelvic cancer, data from early stage trials showed on Wednesday. The drug, called vorinostat and sold in the United States under the name Zolinza, is a new type of therapy called a histone deacetylase [...]
Continue reading...Wednesday, November 4, 2009
Most adults transition to their post-cancer treatment lives needing minimal or no healthcare support, but a significant proportion of cancer survivors continue to have multiple unmet physical and mental health needs, hint study findings from the United Kingdom. In post-treatment surveys of 1,425 cancer survivors, 34 percent indicated having five or more unmet physical or mental [...]
Continue reading...
Wednesday, April 7, 2010
0 Comments